Xtant Medical Holdings, Inc. (XTNT) Social Stream



Xtant Medical Holdings, Inc. (XTNT): $1.11

0.04 (-3.07%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

XTANT MEDICAL HOLDINGS INC (XTNT) Price Targets From Analysts

Use the tables below to see what analysts covering XTANT MEDICAL HOLDINGS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-04-26 1 $1 $1 $1 $1.21 -17.36%
2023-07-11 1 $1.2 $1.2 $1.2 $1.21 -0.83%
NA 1 $NA $NA $NA $1.21 NA%

Price Target Last Issued July 11, 2023

XTNT reports an average of 53.82% for its upside potential over the past 76 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-26 1 1.0 1.0 1.0 0.627 59.49%
2023-07-11 1 1.2 1.2 1.2 0.810 48.15%

XTNT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • XTANT MEDICAL HOLDINGS INC's number of analysts covering the stock is greater than practically none of all US stocks.
  • XTANT MEDICAL HOLDINGS INC's variance in analysts' estimates is lower than nearly 100% of all US stocks.
  • In terms of how XTANT MEDICAL HOLDINGS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 0.61% of that group.
  • XTNT has a greater upside potential (average analyst target price relative to current price) than 11.78% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to XTANT MEDICAL HOLDINGS INC are ADMA, PALI, and CRDF.

Is XTNT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!